Satishkumar Singh

Satishkumar Singh's research focuses on cancer biology, particularly colorectal cancer, using patient-derived organoids (lab-grown mini-tumors from patient tissue) and xenografts (patient tumor tissue grown in lab animal models) to study rare and difficult-to-treat cancer subtypes, such as colorectal signet ring cell carcinoma. The associated topic list also touches on lymphoma, chronic lymphocytic leukemia, Wnt/β-catenin signaling (a cell communication pathway often disrupted in cancer), and RNA modifications linked to cancer, suggesting broader interests in cancer molecular biology. Recent published output centers heavily on a single large 2025 study identifying therapeutic vulnerabilities in colorectal signet ring cell carcinoma, along with its extensive supplementary data files.

Publication output was low and irregular for much of the past decade but shows a sharp recent increase, with a large spike in 2025 driven largely by one major study and its supplementary materials.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026